P.P. Koopmans
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 20
- HIV/AIDS Research and Interventions 6
- Epidemiology 14
- Pneumocystis jirovecii pneumonia detection and treatment 11
- Co-authors
- Y. A. Hekster (9 shared papers)David M. Burger (9 shared papers)E.W. Wuis (6 shared papers)T. B. Vree (4 shared papers)J.W.M. van der Meer (4 shared papers)Patricia W. H. Hugen (3 shared papers)F. W. J. Gribnau (2 shared papers)C.P.W.G.M. Verwey-van Wissen (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)Journal of Chromatography B (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)Analytical Biochemistry (1 paper)Journal of NeuroVirology (1 paper)
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
P.P. Koopmans
34 papers receiving 967 citations
Peers
Comparison fields: 5 of 82
- Virology 277
- Infectious Diseases 555
- Pharmacology 191
- Emergency Medicine 94
- Hepatology 58
Countries citing papers authored by P.P. Koopmans
This map shows the geographic impact of P.P. Koopmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Koopmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Koopmans more than expected).
Fields of papers citing papers by P.P. Koopmans
This network shows the impact of papers produced by P.P. Koopmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Koopmans. The network helps show where P.P. Koopmans may publish in the future.
Co-authors
The 25 scholars most cited alongside P.P. Koopmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 145 | |
| 2 | 1991 | 125 | |
| 3 | 1999 | 95 | |
| 4 | Simultaious determination of the HIV protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. | 1999 | 65 |
| 5 | 2000 | 60 | |
| 6 | 1984 | 56 | |
| 7 | 1997 | 51 | |
| 8 | 2007 | 51 | |
| 9 | 2015 | 45 | |
| 10 | 1995 | 45 | |
| 11 | Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography | 1997 | 30 |
| 12 | 1994 | 30 | |
| 13 | 1996 | 26 | |
| 14 | 1987 | 24 | |
| 15 | 1984 | 23 | |
| 16 | 2001 | 19 | |
| 17 | 2003 | 16 | |
| 18 | Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration? | 2009 | 16 |
| 19 | 2010 | 13 | |
| 20 | Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity. | 2003 | 13 |
About P.P. Koopmans
P.P. Koopmans is a scholar working on Infectious Diseases, Epidemiology, Virology, Emergency Medicine and Pharmacology, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (6 papers), HIV-related health complications and treatments (4 papers), Hepatitis C virus research (3 papers), Vitamin K Research Studies (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Virology (277 citations), Infectious Diseases (555 citations), Pharmacology (191 citations), Emergency Medicine (94 citations) and Hepatology (58 citations). P.P. Koopmans has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Y. A. Hekster, David M. Burger, E.W. Wuis, T. B. Vree, J.W.M. van der Meer, Patricia W. H. Hugen, F. W. J. Gribnau, C.P.W.G.M. Verwey-van Wissen, D.M. Burger and T Thien. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Chromatography B, Journal of Antimicrobial Chemotherapy, Analytical Biochemistry and Journal of NeuroVirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.